454 related articles for article (PubMed ID: 1325636)
21. Ganciclovir implants: one year later.
Cadman J
GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
[TBL] [Abstract][Full Text] [Related]
22. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
[TBL] [Abstract][Full Text] [Related]
23. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
;
N Engl J Med; 1992 Jan; 326(4):213-20. PubMed ID: 1345799
[TBL] [Abstract][Full Text] [Related]
24. Foscarnet approved for cytomegalovirus retinitis.
Am Fam Physician; 1991 Nov; 44(5):1890. PubMed ID: 1659165
[No Abstract] [Full Text] [Related]
25. Cytomegalovirus pneumonia: presentation, diagnosis, and treatment.
Ljungman P
Semin Respir Infect; 1995 Dec; 10(4):209-15. PubMed ID: 8668848
[TBL] [Abstract][Full Text] [Related]
26. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
[TBL] [Abstract][Full Text] [Related]
27. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
28. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
29. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
Bone Marrow Transplant; 1993 Oct; 12(4):399-403. PubMed ID: 8275040
[TBL] [Abstract][Full Text] [Related]
30. Management of cytomegalovirus disease with antiviral drugs.
Balfour HH
Rev Infect Dis; 1990; 12 Suppl 7():S849-60. PubMed ID: 2173114
[TBL] [Abstract][Full Text] [Related]
31. Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy.
Jacobson MA; O'Donnell JJ; Porteous D; Brodie HR; Feigal D; Mills J
Q J Med; 1988 Jun; 67(254):473-86. PubMed ID: 2854894
[TBL] [Abstract][Full Text] [Related]
32. [Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
Gluckman E; McMazeron ; Keable H; Meletis J; Bombail D; Jolivet I; Huart JJ; Nebout T; Cavazzana M; De Castro H
Nouv Rev Fr Hematol (1978); 1987; 29(1):17-21. PubMed ID: 3035485
[TBL] [Abstract][Full Text] [Related]
33. Problems in the management of cytomegalovirus infection in patients with AIDS.
Connolly GM; Nelson MR; Barton SE; Gazzard BG
Int J STD AIDS; 1991; 2(6):405-10. PubMed ID: 1664242
[No Abstract] [Full Text] [Related]
34. Foscarnet.
Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
[No Abstract] [Full Text] [Related]
35. Simultaneous treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.
Nelson MR; Barter G; Hawkins D; Gazzard BG
Lancet; 1991 Jul; 338(8761):250. PubMed ID: 1676798
[No Abstract] [Full Text] [Related]
36. [Therapeutic alternative or 2d choice drug. Trisodium phosphonoformate in cytomegalovirus retinitis].
Gümbel H; Ohrloff C; Schalnus R; Helm EB
Fortschr Ophthalmol; 1991; 88(6):731-4. PubMed ID: 1665472
[TBL] [Abstract][Full Text] [Related]
37. Didanosine and foscarnet marketed for use by patients with AIDS.
Clin Pharm; 1992 Jan; 11(1):4, 6. PubMed ID: 1309689
[No Abstract] [Full Text] [Related]
38. Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus.
Butler KM; De Smet MD; Husson RN; Mueller B; Manjunath K; Montrella K; Lovato G; Jarosinski P; Nussenblatt RB; Pizzo PA
J Pediatr; 1992 Mar; 120(3):483-6. PubMed ID: 1311378
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of cytomegalovirus infections in immunosuppressed patients].
Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
[No Abstract] [Full Text] [Related]
40. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
Control Clin Trials; 1992 Feb; 13(1):22-39. PubMed ID: 1315661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
